The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Targeted Treatments for Cognitive and Neurodevelopmental Disorders in Tuberous Sclerosis Complex
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, early phase clinical trials suggest that cognitive features of TSC may be reversible in adult humans (44).”
From Modeling Autistic Features in Animals (2011) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Pten Regulates Neuronal Arborization and Social Interaction in Mice
Kwon, C.-H., Luikart, B. W., Powell, C. M., Zhou, J., Matheny, S. A., Zhang, W., Li, Y., Baker, S. J., & Parada, L. F. (2006) · Neuron · doi:10.1016/j.neuron.2006.03.023 · Cited by 970
Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis
Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 882
The Autistic Neuron: Troubled Translation?
Kelleher, R. J., & Bear, M. F. (2008) · Cell · doi:10.1016/j.cell.2008.10.017 · Cited by 598
Wong, M. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02341.x · Cited by 205
Fragile X: Leading the Way for Targeted Treatments in Autism
Wang, L. W., Berry-Kravis, E., & Hagerman, R. J. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.005 · Cited by 176
Ehninger, D., De Vries, P. J., & Silva, A. J. (2009) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2009.01208.x · Cited by 120 · cited 2×
“The neuropsychiatry of TSC The neuropsychiatry of TSC is highly complex and often leads to the most problematic clinical challenges for families.(11,12) Approximately 30% of individuals have profound intellectual disability with developmental quotients below Address correspondence and reprint requests to: Petrus J.”
BackgroundMozaffari, M., Hoogeveen-Westerveld, M., Kwiatkowski, D., Sampson, J., Ekong, R., Povey, S., den Dunnen, J. T., van den Ouweland, A., Halley, D., & Nellist, M. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-88 · Cited by 36
Research works printed but not linked: 44
- de Vries, 2007, The tuberous sclerosis complex proteins–a GRIPP on cognition and neurodevelopment, Trends Mol Med, 13, 319, 10.1016/j.molmed.2007.06.003 · DOI · Paper page
- Jones, 1997, Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis, Hum Mol Genet, 6, 2155, 10.1093/hmg/6.12.2155 · DOI · Paper page
- Dabora, 2001, Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs, Am J Hum Genet, 68, 64, 10.1086/316951 · DOI · Paper page
- Roach, 1998, Tuberous sclerosis consensus conference: revised diagnostic criteria, J Child Neurol, 13, 624, 10.1177/088307389801301206 · DOI · Paper page
- Ridler, 2007, Neuroanatomical correlates of memory deficits in tuberous sclerosis complex, Cereb Cortex, 17, 261, 10.1093/cercor/bhj144 · DOI · Paper page
- Ridler, 2001, Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis, Psychol Med, 31, 1437, 10.1017/S0033291701004561 · DOI
- Franz, 2009, Giant cell astrocytomas in tuberous sclerosis complex, Arch Dis Child, 94, 75
- Franz, 2006, Rapamycin causes regression of astrocytomas in tuberous sclerosis complex, Ann Neurol, 59, 490, 10.1002/ana.20784 · DOI · Paper page
- Prather, 2004, Behavioral and cognitive aspects of tuberous sclerosis complex, J Child Neurol, 19, 666, 10.1177/08830738040190090601 · DOI · Paper page
- Joinson, 2003, Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex, Psychol Med, 33, 335, 10.1017/S0033291702007092 · DOI · Paper page
- de Vries, 2007, The tuberous sclerosis complex, N Engl J Med, 356, 92, 10.1056/NEJMc062928 · DOI · Paper page
- Bolton, 2002, Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex, Brain, 125, 1247, 10.1093/brain/awf124 · DOI · Paper page
- de Vries, 2006, The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families, Eur Child Adolesc Psychiatry, 16, 16, 10.1007/s00787-006-0570-3 · DOI
- Lewis, 2004, Genotype and psychological phenotype in tuberous sclerosis, J Med Genet, 41, 203, 10.1136/jmg.2003.012757 · DOI
- Smalley, 1994, Phenotypic variation of tuberous sclerosis in a single extended kindred, J Med Genet, 31, 761, 10.1136/jmg.31.10.761 · DOI
- de Vries, 2009, Neuropsychological attention deficits in tuberous sclerosis complex (TSC), Am J Med Genet Part A, 149A, 387, 10.1002/ajmg.a.32690 · DOI
- McCartney, 2009, Lateralised spatial attentional bias and white matter tract connectivity in tuberous sclerosis complex (TSC), J Intell Disabil Res, 53, 836
- Sahakian, 1992, Computerized assessment in neuropsychiatry using CANTAB: discussion paper, J Royal Soc Med, 85, 399
- Kwiatkowski, 2005, Tuberous sclerosis: a GAP at the crossroads of multiple signalling pathways, Hum Mol Genet, 14, R251, 10.1093/hmg/ddi260 · DOI · Paper page
- Sampson, 2009, Therapeutic targeting of mTOR in tuberous sclerosis, Biochem Soc Trans, 37, 259, 10.1042/BST0370259 · DOI
- Jacinto, 2004, Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive, Nature Cell Biol, 6, 1122, 10.1038/ncb1183 · DOI · Paper page
- Serfontein, 2010, Evolution of the TSC1/TSC2-TOR signalling pathway, Sci Signal, 3, 49, 10.1126/scisignal.2000803 · DOI
- O'Callaghan, 2004, The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex, Arch Dis Child, 89, 530, 10.1136/adc.2003.026815 · DOI · Paper page
- Raznahan, 2007, Biological markers of intellectual disability in tuberous sclerosis, Psychol Med, 37, 1293, 10.1017/S0033291707000177 · DOI
- Jozwiak, 2009, New indications for antiepileptic drugs application in infants with tuberous sclerosis complex – prevention of epilepsy, Pharmacol Reports, 61, 580, 10.1016/S1734-1140(09)70104-5 · doi:10.1016/s1734-1140(09)70104-5
- Costa-Mattioli, 2009, Translational control of long-lasting synaptic plasticity and memory, Neuron, 61, 10, 10.1016/j.neuron.2008.10.055 · DOI · Paper page
- Goorden, 2007, Cognitive deficits in Tsc1+/− mice in the absence of cerebral lesions and seizures, Ann Neurol, 62, 648, 10.1002/ana.21317 · DOI · Paper page
- Nellist, 2005, Distinct effects of single amino-acid changes to tuberin on the function of the tuberin-hamartin complex, Eur J Hum Genet, 13, 59, 10.1038/sj.ejhg.5201276 · DOI
- Persico, 2006, Searching for ways out of the autism maze: genetic, epigenetic and environmental clues, Trends Neurosci, 29, 349, 10.1016/j.tins.2006.05.010 · DOI · Paper page
- de Vries, 2009, Genetics and neuropsychiatric disorders: genome-wide, yet narrow, Nat Med, 15, 850, 10.1038/nm0809-850 · DOI
- Johannessen, 2005, The NF1 tumor suppressor critically regulates TSC2 and mTOR, Proc Natl Acad Sci USA, 102, 8573, 10.1073/pnas.0503224102 · DOI · Paper page
- Kenerson, 2005, Effects of rapamycin in the Eker rat model of tuberous sclerosis complex, Pediatr Res, 57, 67, 10.1203/01.PDR.0000147727.78571.07 · DOI · Paper page
- Lee, 2005, Efficacy of a rapamycin analog (CCI-779) and IFN-γ in tuberous sclerosis mouse models, Genes Chromosomes Cancer, 42, 213, 10.1002/gcc.20118 · DOI · Paper page
- Bissler, 2008, Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis, N Engl J Med, 358, 140, 10.1056/NEJMoa063564 · DOI · Paper page
- Davies, 2008, Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis, N Engl J Med, 358, 200, 10.1056/NEJMc072500 · DOI · Paper page
- Hofbauer, 2008, The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis, B J Dermatol, 159, 473, 10.1111/j.1365-2133.2008.08677.x · DOI
- Rauktys, 2008, Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model, BMC Dermatol, 8, 1, 10.1186/1471-5945-8-1 · DOI
- Krueger DA, Care MM, Agricola K, et al. Safety and efficacy of RAD001 (everolimus) for the treatment of subependymal giant cell astrocytoma in pediatric and adult patients with TSC. Presented at the TSC International Research Conference, University of Sussex; September 11–13, 2008; Brighton, UK.
- Zeng, 2008, Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex, Ann Neurol, 63, 444, 10.1002/ana.21331 · DOI · Paper page
- Meikle, 2008, Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signalling lead to improved survival and function, J Neurosci, 28, 5422, 10.1523/JNEUROSCI.0955-08.2008 · DOI · Paper page
- Krueger DA, Holland-Bouley K, Byers AW, et al. Effect of RAD001 (everolimus) on epilepsy and neurocognition in patients with TSC. Presented at the TSC International Research Conference, University of Sussex; September 11–13, 2008; Brighton, UK.
- Chen, 2005, PI3 kinase signalling is required for retrieval and extinction of contextual memory, Nat Neurosci, 8, 925, 10.1038/nn1482 · DOI · Paper page
- Dash, 2006, Spatial memory formation and memory-enhancing effect of glucose involves activation of the tuberous sclerosis complex-mammalian target of rapamycin pathway, J Neurosci, 26, 8048, 10.1523/JNEUROSCI.0671-06.2006 · DOI · Paper page
- de Vries PJ. The Neuroscience of TSC – are we at risk of getting lost between the bench and the bedside? Presented at the International TSC Research Conference: From DNA to Human Therapies; September 23–26, 2009; Chicago.
Cited by
A developmental and genetic classification for malformations of cortical development: update 2012
Barkovich, A. J., Guerrini, R., Kuzniecky, R. I., Jackson, G. D., & Dobyns, W. B. (2012) · Brain · doi:10.1093/brain/aws019 · Cited by 1,104
Zoghbi, H. Y., & Bear, M. F. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009886 · Cited by 797
Neurological and neuropsychiatric aspects of tuberous sclerosis complex
Curatolo, P., Moavero, R., & de Vries, P. J. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00069-1 · Cited by 600
Tuberous Sclerosis Associated Neuropsychiatric Disorders (TAND) and the TAND Checklist
de Vries, P. J., Whittemore, V. H., Leclezio, L., Byars, A. W., Dunn, D., Ess, K. C., Hook, D., King, B. H., Sahin, M., & Jansen, A. (2015) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.10.004 · Cited by 371
Bateup, H. S., Johnson, C. A., Denefrio, C. L., Saulnier, J. L., Kornacker, K., & Sabatini, B. L. (2013) · Neuron · doi:10.1016/j.neuron.2013.03.017 · Cited by 330
Metadata
- Authors
- de Vries, P. J.
- Venue
- Neurotherapeutics
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 7
- Issue
- 3
- Pages
- 275-282
- ISSN
- 1878-7479
- Cited by
- 91
- References
- 9
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4789 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.